Aptuit Consulting was established as an independent business unit of Aptuit during 2006 in recognition of the need to bring an independent team of experts together who understand the entire drug development process. As such, we are committed to meeting the needs of our clients by providing unbiased guidance and advice.
Our dedicated and diverse teams of drug development experts all have first-hand experience and proven track records in managing all phases of drug development programs, from drug discovery through clinical trials and registration. Unlike independent consultants or other consulting groups, Aptuit Consulting is capable of developing and managing the entire drug development process, from API to proof-of-concept, for a wide variety of drugs and medical devices in many different therapeutic areas. Our expertise also includes regulatory strategy and submission as well as oversight of intellectual property defense through all stages of patent prosecution and litigation including depositions and trial testimony in the U.S. and abroad.
The research and development of new medical products is a complex, costly and time-consuming process where there is no substitute for experience. For some time now the biomedical industry has been under pressure to become more efficient as the cost of taking a new drug into the clinic continues to rise while the approval rate of innovative new therapies has declined. These dynamics have led virtual, small and emerging biotechnology companies to large pharmaceutical icons alike, to look for ways that they can gain both short and long-term advantages through strategic outsourcing and partnerships.